M&A / Property
Rapid Dose, Eco work on harm reduction pilot project

DOSE · Price
Executive Summary
- Rapid Dose Therapeutics Corp. has launched a two-year harm reduction pilot project in collaboration with Eco Canadian Organic Inc., funded by Health Canada.
- The initiative targets First Nations communities in Canada to address the opioid crisis using "Replace+," a sublingual cannabis strip utilizing Rapid Dose's proprietary QuickStrip technology.
- The project aims to provide an alternative delivery method to help individuals manage opioid withdrawal symptoms and transition away from opioid dependence, with plans to expand to other First Nations communities.
Key Details
- Partnership: Collaboration between Rapid Dose Therapeutics Corp. and Eco Canadian Organic Inc.
- Project Name: Substance Use and Addictions Program (SUAP) Harm Reduction Pilot Project.
- Funding Source: Health Canada.
- Duration: Two-year pilot project.
- Target Audience: First Nations communities in Canada, which are disproportionately affected by the opioid crisis.
- Product: "Replace+," an Eco-branded sublingual cannabis strip.
- Technology: Utilizes Rapid Dose’s proprietary QuickStrip technology for fast-acting, convenient, and precise delivery of active ingredients.
- Objective: To serve as a harm reduction tool, supporting individuals in transitioning away from opioid dependence and managing withdrawal symptoms.
- Strategic Goal: To pioneer harm-reductive and pharma-reductive applications of cannabinoids and expand the program to other First Nations communities.
Notable Quotes
- Mark Upsdell, CEO of Rapid Dose Therapeutics: "We are incredibly honoured to be part of this project, which represents a critical step in addressing the opioid crisis in Canada's indigenous communities... Our QuickStrip technology has the potential to offer a much needed alternative in the ongoing fight to reduce opioid-related harm..."
- Denise Hannay, CEO of Eco Canadian: "The opioid crisis has had a devastating impact on our first nations people, and it is imperative that we explore every possible option to support those who are suffering. The QuickStrip technology, through the Replace+ brand, offers a promising new avenue for harm reduction..."
More from Rapid Dose Therapeutics Corp
Apr 13, 2026 · 09:51